149 related articles for article (PubMed ID: 28099396)
1. Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide.
Uppuluri R; Ramachandrakurup S; Balaji R; Subburaj D; Bakane A; Raj R
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e74-e78. PubMed ID: 28099396
[TBL] [Abstract][Full Text] [Related]
2. Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children.
Uppuluri R; Ramachandrakurup S; Subburaj D; Bakane A; Raj R
Pediatr Blood Cancer; 2017 Jan; 64(1):110-112. PubMed ID: 27555565
[TBL] [Abstract][Full Text] [Related]
3. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
4. Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine.
Ottaviano F; Finlay JL
J Pediatr Hematol Oncol; 2003 Jul; 25(7):575-7. PubMed ID: 12847329
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
Choi SW; Bangaru BS; Wu CD; Finlay JL
J Pediatr Hematol Oncol; 2003 Jun; 25(6):503-6. PubMed ID: 12794533
[TBL] [Abstract][Full Text] [Related]
6. Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis.
Rosso DA; Amaral D; Latella A; Chantada G; Braier JL
Br J Haematol; 2016 Jan; 172(2):287-90. PubMed ID: 25944303
[No Abstract] [Full Text] [Related]
7. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
Donadieu J; Bernard F; van Noesel M; Barkaoui M; Bardet O; Mura R; Arico M; Piguet C; Gandemer V; Armari Alla C; Clausen N; Jeziorski E; Lambilliote A; Weitzman S; Henter JI; Van Den Bos C;
Blood; 2015 Sep; 126(12):1415-23. PubMed ID: 26194764
[TBL] [Abstract][Full Text] [Related]
8. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
[TBL] [Abstract][Full Text] [Related]
9. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
10. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
[TBL] [Abstract][Full Text] [Related]
12. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.
Abraham A; Alsultan A; Jeng M; Rodriguez-Galindo C; Campbell PK
Pediatr Blood Cancer; 2013 Jun; 60(6):E19-22. PubMed ID: 23255383
[TBL] [Abstract][Full Text] [Related]
13. Immune Thrombocytopenia in a Child With Refractory Langerhans Cell Histiocytosis Following Cladribine Containing Therapy.
Lai CY; Pettit T
J Pediatr Hematol Oncol; 2019 Nov; 41(8):620-623. PubMed ID: 29889804
[TBL] [Abstract][Full Text] [Related]
14. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cell histiocytosis, a case of Letterer Siwe disease.
Pant C; Madonia P; Bahna SL; Bass PF; Jeroudi M
J La State Med Soc; 2009; 161(4):211-2. PubMed ID: 19785312
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of adult multisystemic Langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine.
von Stebut E; Schadmand-Fischer S; Bräuninger W; Kreft A; Doberauer C; Steinbrink K
Arch Dermatol; 2008 May; 144(5):649-53. PubMed ID: 18490592
[TBL] [Abstract][Full Text] [Related]
17. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
[TBL] [Abstract][Full Text] [Related]
18. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
Yao X; Ying H; Weihong Z; Qing S; Xintian L
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Langerhans cell histiocytosis with a modified risk-adapted protocol-experience from a tertiary cancer institute in India.
Narula G; Pradhan ND; Arora B; Banavali SD
Pediatr Blood Cancer; 2018 Aug; 65(8):e27028. PubMed ID: 29512864
[TBL] [Abstract][Full Text] [Related]
20. Drug therapy for the treatment of Langerhans cell histiocytosis.
McClain KL
Expert Opin Pharmacother; 2005 Nov; 6(14):2435-41. PubMed ID: 16259575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
